Literature DB >> 7041636

Specificity of eluted antibody from renal tissues of patients with IgA nephropathy.

Y Tomino, M Endoh, Y Nomoto, H Sakai.   

Abstract

A study on the specificity of antibodies eluted from renal biopsy specimens in patients with IgA nephropathy is described. Renal biopsy specimens were obtained from patients with IgA nephropathy and other glomerular diseases. These specimens were treated with citrate buffer (pH 3.2) and the "eluate" was neutralized by sodium hydroxide. The "eluate" was then applied to the acid-treated sections obtained from the same and other patients with IgA nephropathy as well as to those with other glomerular diseases. The sections were stained with FITC-labeled heavy-chain-specific anti-human IgA antisera and examined with a fluorescent microscope. It was demonstrated that the antibodies obtained from patients with IgA nephropathy specifically recombined with the glomerular mesangial areas in such patients, while these antibodies did not combine with renal tissues obtained from patients with out IgA nephropathy. The eluted antibodies combined with autologous tissues, but only one-third of them combined with allogeneic renal specimens with IgA nephropathy. It is concluded that IgA antibodies deposited in glomeruli are specific to mesangial areas of patients with IgA nephropathy and that these antibodies show some heterogeneity among patients with this disorder.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7041636     DOI: 10.1016/s0272-6386(82)80025-5

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  12 in total

1.  IgA-containing immune complexes after challenge with food antigens in patients with IgA nephropathy.

Authors:  S Jackson; Z Moldoveanu; K A Kirk; B A Julian; T F Patterson; A L Mullins; T Jilling; J Mestecky; J H Galla
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

2.  Detection and characterization of circulating and glomerular immune complexes in experimental IgA nephropathy.

Authors:  J González-Cabrero; J Egido; A Barat; E González
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

Review 3.  Potential Involvement of Peroxisome in Multiple Sclerosis and Alzheimer's Disease : Peroxisome and Neurodegeneration.

Authors:  Amira Zarrouk; Thomas Nury; Hammam I El Hajj; Catherine Gondcaille; Pierre Andreoletti; Thibault Moreau; Mustapha Cherkaoui-Malki; Johannes Berger; Mohamed Hammami; Gérard Lizard; Anne Vejux
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

4.  IgA nephropathy presenting clinicopathological features of acute post-streptococcal glomerulonephritis.

Authors:  K Okada; S Saitoh; Z Sakaguchi; R J Zhang; T Kuhara; K Yasutomo; Y Kuroda
Journal:  Eur J Pediatr       Date:  1996-04       Impact factor: 3.183

5.  Mesangial IgA nephropathies--steady progress.

Authors:  W G Couser
Journal:  West J Med       Date:  1984-01

6.  Quantitation of human serum polymeric IgA, IgA1 and IgA2 immunoglobulin by enzyme immunoassay.

Authors:  C Jones; N Mermelstein; P Kincaid-Smith; H Powell; D Roberton
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

7.  Cross-reactivity of IgA antibodies between renal mesangial areas and nuclei of tonsillar cells in patients with IgA nephropathy.

Authors:  Y Tomino; H Sakai; M Endoh; T Suga; M Miura; H Kaneshige; Y Nomoto
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

Review 8.  Immunopathogenesis of IgAN.

Authors:  Jonathan Barratt; Alice C Smith; Karen Molyneux; John Feehally
Journal:  Semin Immunopathol       Date:  2007-09-13       Impact factor: 9.623

9.  Detection of polymeric IgA in glomeruli from patients with IgA nephropathy.

Authors:  Y Tomino; H Sakai; M Miura; M Endoh; Y Nomoto
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

10.  Immunofluorescent studies on alpha 2-plasmin inhibitor (alpha 2-PI) in glomeruli from patients with IgA nephropathy.

Authors:  M Miura; Y Tomino; M Yagame; M Endoh; T Suga; Y Nomoto; H Sakai
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.